Adjuvant therapy of primary breast cancer

نویسندگان
چکیده

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Adjuvant therapy in primary breast cancer.

This article considers the role of adjuvant therapy in primary breast cancer, utilizing data from randomized prospective clinical trials as illustrative examples. The ongoing efforts targeted toward addressing some of the unresolved issues are underscored.

متن کامل

Adjuvant therapy of primary breast cancer: Consensus Conference, St. Gallen

he International Consensus Conference in St. Gallen, Switzerland, on adjuvant therapy of primary breast cancer was one of the most important scientific meetings in the field, besides the NIH Consensus Development Conference (1). It brought together about 3,000 people. The abstracts were published in the Supplement 1 of the journal The Breast. The Consensus Statements are expected to be publishe...

متن کامل

Adjuvant Systemic Therapy of Breast Cancer

patients younger than 50 years of 12%, and of endocrine therapy of 12%, as well as for patients older than 50 years with endocrine-responsive disease, with regard to disease-free survival with a follow-up time of 15 years [1]. In HER2/neu-overexpressing breast cancer there is an even larger benefit for patients treated with adjuvant chemotherapy in combination with the antibody trastuzumab (app...

متن کامل

[Adjuvant chemotherapy in primary breast cancer].

Adjuvant chemotherapy reduces the relative risk of relapse by about 25%--independent of the nodal status. Anthracycline-containing regimens are considered standard for adjuvant chemotherapy. In single studies, superiority to CMF has only been shown for anthracycline-containing polychemotherapies with at least three substances or a sequential anthracycline-CMF therapy. Recent data show that addi...

متن کامل

Selecting adjuvant endocrine therapy for breast cancer.

This year alone, more than 215,000 women in the United States will be diagnosed with, and over 40,000 will die from, invasive breast cancer. Recently, mortality from female breast cancer has declined despite an increase in its incidence. This decline corresponds with improved screening for prompt tumor detection, and advances in the treatment of early disease. Of these, endocrine therapy has pl...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: Annals of Oncology

سال: 1992

ISSN: 0923-7534

DOI: 10.1093/oxfordjournals.annonc.a058099